Epitracker, Inc.
San Diego, CA Doing business as Epitracker Seraphina Therapeutics
- UEI
- UQNNE3H22VP8
- CAGE
- 7NA02
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 2867 Farragut Rd, San Diego, CA 92106, USA
- Website
- epitracker.com
- Founded
- 2008
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Industrials
- Commercial & Professional Services
- Professional Services
- Consulting
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Advancing navy dolphin genomic data to discover novel therapeutics for chronic, aging-associated conditions in navy… | Defense Contract Management Agency | $96,663 | |
| Oral dietary supplement for u.s. Navy dolphins (sbir phase II) | Defense Contract Management Agency | $1,127,695 | |
| Novel ppar-alpha/delta dual agonist ETI-039 to treat pulmonary fibrosis | Defense Health Agency | $3,256,955 | |
| Research and development | Naval Air Warfare Center | $223,597 |
About Epitracker, Inc.
Epitracker Inc., through its Seraphina Therapeutics Division, is a woman-owned small business in San Diego focused on empowering life science and medical institutions to leverage data for strategic decisions and innovative discoveries, translating them into commercial products. The company is registered in SAM.gov and holds business designations including Minority Owned, Self Certified Small Disadvantaged, Economically Disadvantaged Women Small Owned, Woman Owned, and Asian-Pacific American Owned.
Through prime federal contract awards, Epitracker Inc.'s Seraphina Therapeutics Division has provided the Department of the Navy and the Secretary of the Navy's Office of Naval Research with specialized products and services related to Navy dolphin research. In 2021, the division secured a $2.19 million Other Transaction Agreement under the Small Business Innovation Research (SBIR) Phase II program to develop an Oral Dietary Supplement for U.S. Navy Dolphins. This fixed-price award involved delivering the requested oral supplement to support the Office of Naval Research's dolphin research programs over a three-year period. No major subcontractors or set-aside designations were indicated.
Epitracker Inc.'s Seraphina Therapeutics Division has also received prime federal grant awards from agencies such as the Department of the Navy's Secretary of the Navy Office of Naval Research and the Defense Health Agency. In 2023, the division was awarded a $109,980 Project Grant under the Basic and Applied Scientific Research program (CFDA 12.300) to advance Navy dolphin genomic data and discover novel therapeutics for chronic, aging-associated conditions in Navy dolphins. The grant aimed to stimulate research with potential to improve naval operations by supporting studies of health issues in marine mammals working with the Navy. Additionally, in 2020, the division received a $3,256,955 Project Grant from the Defense Health Agency for the development of a novel PPAR-alpha/delta dual agonist ETI-039 to treat pulmonary fibrosis.
Quick answers
What is Epitracker, Inc.'s UEI?
Epitracker, Inc.'s Unique Entity ID (UEI) in SAM.gov is UQNNE3H22VP8.
What is Epitracker, Inc.'s CAGE code?
Epitracker, Inc.'s CAGE code is 7NA02.
What is Epitracker, Inc.'s primary NAICS code?
Epitracker, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Epitracker, Inc. located?
Epitracker, Inc.'s physical address in SAM.gov is 2867 Farragut Rd, San Diego, CA 92106, USA.
Is Epitracker, Inc. registered in SAM.gov?
Yes. Epitracker, Inc.'s SAM.gov registration is active through April 13, 2027.
What is Epitracker, Inc.'s most recent federal award?
Epitracker, Inc.'s most recent federal grant award is Advancing navy dolphin genomic data to discover novel therapeutics for chronic, aging-associated conditions in navy… (N000142312462), from Defense Contract Management Agency, on June 1, 2023.
On GovTribe
See Epitracker, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors